VivoSim Labs, Inc. VIVS
0.15 USD +0.03 (+19.47%)
At closeNov 12, 2026, 6:16 AM EST
0.16 0.00 +1.03%
Pre-market · Nov 12, 6:16 AM ET
0.1256 Day range 0.1812
0.12 52-week range 3.40
- YTD
- -91.46%
- 1 year
- -93.16%
- Market cap
- 2.56M
- EPS (ttm)
- -4.47
- YTD return
- -91.46%
- 1-year return
- -93.16%
- Volume
- 6.88M
- Avg volume
- 936.14K
- Open
- 0.1313
- Previous close
- 0.1294
- Day's range
- 0.1256 – 0.1812
- 52-week range
- 0.12 – 3.40
5D +0.0024 (+1.58%)
Financials — quick view
VIVS Revenue — quarterly 18.00K
VIVS Net income — quarterly -1.34M
VIVS EPS — quarterly -0.25
News
VivoSim Labs to Showcase Multiparametric Human 3D Tissue Safety Data at the American College of Toxicology (ACT) 47th Annual Meeting 
VivoSim Labs Partners With Chemveda Life Sciences To Test, Screen AI-Derived Drug Compounds In VivoSim's NAMkind 3D Tissue Models 
VivoSim Labs To Extend Its Human Tissue Platform Beyond Toxicology With Efficacy Testing Services Built On NAMkind Disease Models Of The Liver And Intestine 
12 Health Care Stocks Moving In Monday's After-Market Session
Your note
Sign in to keep a note on VIVS — it syncs with the Stock Master app.